De novo fatty acid synthesis at the mitotic exit is required to complete cellular division

Cell Cycle

Volumn 13, Issue 5, 2014, Pages 859-868

  Scaglia, Natalia ^a,g   Tyekucheva, Svitlana ^b,c   Zadra, Giorgia ^a,d   Photopoulos, Cornelia ^a   Loda, Massimo ^a,d,e,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g INSTITUTO DE INVESTIGACIONES BIOQUÍMICAS DE LA PLATA INIBIOLP   (Argentina)

Author keywords

AMPK; C75; Cell cycle; Cell cycle arrest; De novo lipogenesis; Fatty acid; Lysophospholipid; Metabolome; Phospholipid

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CITICOLINE; CYCLIN B1; FATTY ACID; GLUCOSE; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHOLIPID; PHOSPHATIDYLCHOLINE; PHOSPHORYLCHOLINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIVISION; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINESIS; FATTY ACID SYNTHESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HELA CELL; HUMAN; HUMAN CELL; LIPID STORAGE; MASS SPECTROMETRY; METAPHASE; MITOSIS; PROTEIN CONTENT; PROTEIN DETERMINATION; TELOPHASE; BIOSYNTHESIS; CELL CYCLE G1 PHASE; G2 PHASE CELL CYCLE CHECKPOINT; HELA CELL LINE; METABOLISM; PHYSIOLOGY;

ACETYL-COA CARBOXYLASE; AMP-ACTIVATED PROTEIN KINASES; CELL DIVISION; FATTY ACIDS; G1 PHASE; G2 PHASE CELL CYCLE CHECKPOINTS; HELA CELLS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MITOSIS;

EID: 84898007635     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.27767     Document Type: Article

References (57)

1. Bergeron JJ, Warmsley AM, Pasternak CA. Phospholipid synthesis and degradation during the life-cycle of P815Y mast cells synchronized with excess of thymidine. Biochem J 1970; 119:489-92; PMID:5500308
2. Warmsley AM, Pasternak CA. The use of conventional and zonal centrifugation to study the life cycle of mammalian cells. Phospholipid and macromolecular synthesis in neoplastic mast cells. Biochem J 1970; 119:493-9; PMID:5500309
3. Graham JM, Sumner MC, Curtis DH, Pasternak CA. Sequence of events in plasma membrane assembly during the cell cycle. Nature 1973; 246:291-5; PMID:4271386; http://dx.doi.org/10.1038/246291a0
4. Jackowski S. Coordination of membrane phospholipid synthesis with the cell cycle. J Biol Chem 1994; 269:3858-67; PMID:8106431
5. Northwood IC, Tong AH, Crawford B, Drobnies AE, Cornell RB. Shuttling of CTP:Phosphocholine cytidylyltransferase between the nucleus and endoplasmic reticulum accompanies the wave of phosphatidylcholine synthesis during the G(0) → G(1) transition. J Biol Chem 1999; 274:26240-8; PMID:10473578; http://dx.doi.org/10.1074/jbc.274.37.26240
6. Golfman LS, Bakovic M, Vance DE. Transcription of the CTP:phosphocholine cytidylyltransferase alpha gene is enhanced during the S phase of the cell cycle. J Biol Chem 2001; 276:43688-92; PMID:11557772; http://dx.doi.org/10.1074/ jbc.M108170200
7. Manguikian AD, Barbour SE. Cell cycle dependence of group VIA calcium-independent phospholipase A2 activity. J Biol Chem 2004; 279:52881-92; PMID:15385540; http://dx.doi.org/10.1074/jbc.M410659200
8. Banchio C, Schang LM, Vance DE. Phosphorylation of Sp1 by cyclin-dependent kinase 2 modulates the role of Sp1 in CTP:phosphocholine cytidylyltransferase alpha regulation during the S phase of the cell cycle. J Biol Chem 2004; 279:40220-6; PMID:15247247; http://dx.doi.org/10.1074/jbc. M406468200
9. Tercé F, Brun H, Vance DE. Requirement of phosphatidylcholine for normal progression through the cell cycle in C3H/10T1/2 fibroblasts. J Lipid Res 1994; 35:2130-42; PMID:7897311
10. Cui Z, Houweling M, Chen MH, Record M, Chap H, Vance DE, Tercé F. A genetic defect in phosphatidylcholine biosynthesis triggers apoptosis in Chinese hamster ovary cells. J Biol Chem 1996; 271:14668-71; PMID:8663247; http://dx.doi.org/10.1074/jbc.271.25.14668
11. Bluemink JG, de Laat SW. New membrane formation during cytokinesis in normal and cytochalasin B-treated eggs of Xenopus laevis. I. Electron microscope observations. J Cell Biol 1973; 59:89-108; PMID:4356573; http://dx.doi.org/10. 1083/jcb.59.1.89
12. Shuster CB, Burgess DR. Targeted new membrane addition in the cleavage furrow is a late, separate event in cytokinesis. Proc Natl Acad Sci U S A 2002; 99:3633-8; PMID:11891298; http://dx.doi.org/10.1073/pnas.052342699
13. Boucrot E, Kirchhausen T. Endosomal recycling controls plasma membrane area during mitosis. Proc Natl Acad Sci U S A 2007; 104:7939-44; PMID:17483462; http://dx.doi.org/10.1073/pnas.0702511104
14. Bosmann HB, Winston RA. Synthesis of glycoprotein, glycolipid, protein, and lipid in synchronized L5178Y cells. J Cell Biol 1970; 45:23-33; PMID:5458998; http://dx.doi.org/10.1083/jcb.45.1.23
15. Kobayashi T, Pagano RE. Lipid transport during mitosis. Alternative pathways for delivery of newly synthesized lipids to the cell surface. J Biol Chem 1989; 264:5966-73; PMID:2925644
16. Lin W, Arthur G. Phospholipids are synthesized in the G2/M phase of the cell cycle. Int J Biochem Cell Biol 2007; 39:597-605; PMID:17113814; http://dx.doi.org/10.1016/j.biocel.2006.10.011
17. Ellenberg J, Siggia ED, Moreira JE, Smith CL, Presley JF, Worman HJ, Lippincott-Schwartz J. Nuclear membrane dynamics and reassembly in living cells: targeting of an inner nuclear membrane protein in interphase and mitosis. J Cell Biol 1997; 138:1193-206; PMID:9298976; http://dx.doi.org/10.1083/jcb.138.6. 1193
18. Anderson DJ, Hetzer MW. Nuclear envelope formation by chromatin-mediated reorganization of the endoplasmic reticulum. Nat Cell Biol 2007; 9:1160-6; PMID:17828249; http://dx.doi.org/10.1038/ncb1636
19. Kuhajda FP, Jenner K, Wood FD, Hennigar RA, Jacobs LB, Dick JD, Pasternack GR. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci U S A 1994; 91:6379-83; PMID:8022791; http://dx.doi.org/10.1073/pnas.91.14.6379
20. Kuhajda FP. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res 2006; 66:5977-80; PMID:16778164; http://dx.doi.org/10.1158/ 0008-5472.CAN-05-4673
21. Flavin R, Peluso S, Nguyen PL, Loda M. Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol 2010; 6:551-62; PMID:20373869; http://dx.doi.org/10.2217/fon.10.11
22. Zhang J, Yang Y, Wu J. Palmitate impairs cytokinesis associated with RhoA inhibition. Cell Res 2010; 20:492-4; PMID:20231861; http://dx.doi.org/10.1038/ cr.2010.33
23. Banko MR, Allen JJ, Schaffer BE, Wilker EW, Tsou P, White JL, Villén J, Wang B, Kim SR, Sakamoto K, et al. Chemical genetic screen for AMPKα2 substrates uncovers a network of proteins involved in mitosis. Mol Cell 2011; 44:878-92; PMID:22137581; http://dx.doi.org/10.1016/j.molcel.2011.11. 005
24. Bengoechea-Alonso MT, Punga T, Ericsson J. Hyperphosphorylation regulates the activity of SREBP1 during mitosis. Proc Natl Acad Sci U S A 2005; 102:11681-6; PMID:16081540; http://dx.doi.org/10.1073/pnas.0501494102
25. Bengoechea-Alonso MT, Ericsson J. Cdk1/cyclin B-mediated phosphorylation stabilizes SREBP1 during mitosis. Cell Cycle 2006; 5:1708-18; PMID:16880739; http://dx.doi.org/10.4161/cc.5.15.3131
26. Vander Heiden MG. Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov 2011; 10:671-84; PMID:21878982; http://dx.doi.org/10. 1038/nrd3504
27. Aguilar V, Fajas L. Cycling through metabolism. EMBO Mol Med 2010; 2:338-48; PMID:20721988; http://dx.doi.org/10.1002/emmm.201000089
28. Almeida A, Bolaños JP, Moncada S. E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation. Proc Natl Acad Sci U S A 2010; 107:738-41; PMID:20080744; http://dx.doi.org/10. 1073/pnas.0913668107
29. Ray H, Suau F, Vincent A, Dalla Venezia N. Cell cycle regulation of the BRCA1/acetyl-CoA-carboxylase complex. Biochem Biophys Res Commun 2009; 378:615-9; PMID:19061860; http://dx.doi.org/10.1016/j.bbrc.2008.11.090
30. Wieprecht M, Wieder T, Paul C, Geilen CC, Orfanos CE. Evidence for phosphorylation of CTP:phosphocholine cytidylyltransferase by multiple proline-directed protein kinases. J Biol Chem 1996; 271:9955-61; PMID:8626633; http://dx.doi.org/10.1074/jbc.271.17.9955
31. Shah MA, Schwartz GK. Cell cycle-mediated drug resistance: an emerging concept in cancer therapy. Clin Cancer Res 2001; 7:2168-81; PMID:11489790
32. Bettuzzi S, Davalli P, Astancolle S, Pinna C, Roncaglia R, Boraldi F, Tiozzo R, Sharrard M, Corti A. Coordinate changes of polyamine metabolism regulatory proteins during the cell cycle of normal human dermal fibroblasts. FEBS Lett 1999; 446:18-22; PMID:10100606; http://dx.doi.org/10.1016/S0014- 5793(99)00182-9
33. Brand K, Aichinger S, Forster S, Kupper S, Neumann B, Nürnberg W, Ohrisch G. Cell-cycle-related metabolic and enzymatic events in proliferating rat thymocytes. Eur J Biochem 1988; 172:695-702; PMID:3258238; http://dx.doi.org/10.1111/j.1432-1033.1988.tb13944.x
34. Geley S, Kramer E, Gieffers C, Gannon J, Peters JM, Hunt T. Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J Cell Biol 2001; 153:137-48; PMID:11285280; http://dx.doi.org/10. 1083/jcb.153.1.137
35. Clute P, Pines J. Temporal and spatial control of cyclin B1 destruction in metaphase. Nat Cell Biol 1999; 1:82-7; PMID:10559878; http://dx.doi.org/10. 1038/10049
36. Zadra G, Photopoulos C, Tyekucheva S, Heidari P, Weng QP, Fedele G, Liu H, Scaglia N, Priolo C, Sicinska E, et al. A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis. EMBO Mol Med 2014; In press.
37. Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA. The active form of the metabolic sensor: AMP-activated protein kinase (AMPK) directly binds the mitotic apparatus and travels from centrosomes to the spindle midzone during mitosis and cytokinesis. Cell Cycle 2009; 8:2385-98; PMID:19556893; http://dx.doi.org/10.4161/cc.8.15.9082
38. Jackowski S. Cell cycle regulation of membrane phospholipid metabolism. J Biol Chem 1996; 271:20219-22; PMID:8702749
39. Saitoh S, Takahashi K, Nabeshima K, Yamashita Y, Nakaseko Y, Hirata A, Yanagida M. Aberrant mitosis in fission yeast mutants defective in fatty acid synthetase and acetyl CoA carboxylase. J Cell Biol 1996; 134:949-61; PMID:8769419; http://dx.doi.org/10.1083/jcb.134.4.949
40. Al-Feel W, DeMar JC, Wakil SJ. A Saccharomyces cerevisiae mutant strain defective in acetyl-CoA carboxylase arrests at the G2/M phase of the cell cycle. Proc Natl Acad Sci U S A 2003; 100:3095-100; PMID:12626751; http://dx.doi.org/10.1073/pnas.0538069100
41. Li JN, Gorospe M, Chrest FJ, Kumaravel TS, Evans MK, Han WF, Pizer ES. Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. Cancer Res 2001; 61:1493-9; PMID:11245456
42. Gao Y, Lin LP, Zhu CH, Chen Y, Hou YT, Ding J. Growth arrest induced by C75, A fatty acid synthase inhibitor, was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma. Cancer Biol Ther 2006; 5:978-85; PMID:16855382; http://dx.doi.org/10.4161/cbt.5.8.2883
43. Horiguchi A, Asano T, Asano T, Ito K, Sumitomo M, Hayakawa M. Pharmacological inhibitor of fatty acid synthase suppresses growth and invasiveness of renal cancer cells. J Urol 2008; 180:729-36; PMID:18555493; http://dx.doi.org/10.1016/j.juro.2008.03.186
44. Knowles LM, Smith JW. Genome-wide changes accompanying knockdown of fatty acid synthase in breast cancer. BMC Genomics 2007; 8:168; PMID:17565694; http://dx.doi.org/10.1186/1471-2164-8-168
45. Niculescu MD, da Costa KA, Fischer LM, Zeisel SH. Lymphocyte gene expression in subjects fed a low-choline diet differs between those who develop organ dysfunction and those who do not. Am J Clin Nutr 2007; 86:230-9; PMID:17616785
46. Modolell M, Andreesen R, Pahlke W, Brugger U, Munder PG. Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids. Cancer Res 1979; 39:4681-6; PMID:498095
47. Engebraaten O, Bjerkvig R, Berens ME. Effect of alkyl-lysophospholipid on glioblastoma cell invasion into fetal rat brain tissue in vitro. Cancer Res 1991; 51:1713-9; PMID:1998962
48. Boggs KP, Rock CO, Jackowski S. Lysophosphatidylcholine attenuates the cytotoxic effects of the antineoplastic phospholipid 1-O-octadecyl-2-O-methyl- rac-glycero-3-phosphocholine. J Biol Chem 1995; 270:11612-8; PMID:7744800; http://dx.doi.org/10.1074/jbc.270.19.11612
49. Patel V, Lahusen T, Sy T, Sausville EA, Gutkind JS, Senderowicz AM. Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest. Cancer Res 2002; 62:1401-9; PMID:11888912
50. Igal RA. Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. Carcinogenesis 2010; 31:1509-15; PMID:20595235; http://dx.doi.org/10.1093/ carcin/bgq131
51. Tong L, Harwood HJ Jr. Acetyl-coenzyme A carboxylases: versatile targets for drug discovery. J Cell Biochem 2006; 99:1476-88; PMID:16983687; http://dx.doi.org/10.1002/jcb.21077
52. De Witt Hamer PC, Mir SE, Noske D, Van Noorden CJ, Würdinger T. WEE1 kinase targeting combined with DNA-damaging cancer therapy catalyzes mitotic catastrophe. Clin Cancer Res 2011; 17:4200-7; PMID:21562035; http://dx.doi.org/10.1158/1078-0432.CCR-10-2537
53. Dixon H, Norbury CJ. Therapeutic exploitation of checkpoint defects in cancer cells lacking p53 function. Cell Cycle 2002; 1:362-8; PMID:12548006; http://dx.doi.org/10.4161/cc.1.6.257
54. Whitfield ML, Zheng LX, Baldwin A, Ohta T, Hurt MM, Marzluff WF. Stem-loop binding protein, the protein that binds the 3′ end of histone mRNA, is cell cycle regulated by both translational and posttranslational mechanisms. Mol Cell Biol 2000; 20:4188-98; PMID:10825184; http://dx.doi.org/10. 1128/MCB.20.12.4188-4198.2000
55. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009; 457:910-4; PMID:19212411; http://dx.doi.org/10.1038/nature07762
56. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37:911-7; PMID:13671378; http://dx.doi.org/10.1139/o59-099
57. Scaglia N, Igal RA. Stearoyl-CoA desaturase is involved in the control of proliferation, anchorage-independent growth, and survival in human transformed cells. J Biol Chem 2005; 280:25339-49; PMID:15851470; http://dx.doi.org/10.1074/ jbc.M501159200